ORDERS FLOODING IN FOR BK18

Imo the tree shaking over last couple of trading days hasn't netted any significant volume of shares to be concerned about in the least.

In addition a majority of that volume has been cross trades.  Expecting anyone that wants to accumulate before the next announcement or quarterly is released (before or at the latest next Wednesday) will pay a lot higher than where we are at now.

Also keeping in mind the 16,000 can order outside of Malaysia as stated in the 7 Dec update and what Motley Fool also re-iterated in coverage of BXN 3 Jan 2018.

Bioxyne Ltd (ASX: BXN)
This Australian life sciences and health products company caught the eye last year when it announced plans to launch three health and wellness products into the South East Asia market. The key product, in my opinion, is its BK18 nutritional health drink which is made with dairy from Waikato, New Zealand and includes an immune boosting probiotic and a range of key vitamins. Orders have already flooded in prior to its marketing campaign launching, which could be a very positive sign.

^{https://www.fool.com.au/2018/01/03/3-speculative-small-cap-shares-to-watch-this-year/}